A "nema" of hope in the treatment of late-onset nemaline myopathy.

Dalakas MC, Smith SA. A "nema" of hope in the treatment of late-onset nemaline myopathy. Neurology. 2008 Aug 12; 71(7):472-3.

View in: PubMed

subject areas

Adult
Age of Onset
Clinical Trials as Topic
Humans
Melphalan
Myeloablative Agonists
Myopathies, Nemaline
Stem Cell Transplantation

authors with profiles

Marinos Dalakas

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement